ArticleCureus2024

A Tertiary Centre's Experience With Using Ranibizumab Biosimilar Compared to Aflibercept for Neovascular Age-Related Macular Degeneration: A Retrospective Study.

Ahmed Bilal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.